Your IP : 3.17.165.235


Current Path : /home/ncdcgo/mail/new/
Upload File :
Current File : /home/ncdcgo/mail/new/1729641966.M357217P93954.wh5.nita.go.ug,S=4911,W=5015

Return-Path: <>
Delivered-To: ncdcgo@wh5.nita.go.ug
Received: from wh5.nita.go.ug
	by wh5.nita.go.ug with LMTP
	id gE4mFe49GGcCbwEAzoEFqw
	(envelope-from <>)
	for <ncdcgo@wh5.nita.go.ug>; Wed, 23 Oct 2024 03:06:06 +0300
Return-path: <>
Envelope-to: ncdcgo@wh5.nita.go.ug
Delivery-date: Wed, 23 Oct 2024 03:06:06 +0300
Received: from mailnull by wh5.nita.go.ug with local (Exim 4.97.1)
	id 1t3Ot4-00000000OTX-1649
	for ncdcgo@wh5.nita.go.ug;
	Wed, 23 Oct 2024 03:06:06 +0300
X-Failed-Recipients: elvo8k@gmail.com
Auto-Submitted: auto-replied
From: Mail Delivery System <Mailer-Daemon@wh5.nita.go.ug>
To: ncdcgo@wh5.nita.go.ug
References: <NTKd76us8amVuvz2PONCEz6qy1qBqrtsk2qmHo34tI@ncdc.go.ug>
Content-Type: multipart/report; report-type=delivery-status; boundary=1729641966-eximdsn-1623942687
MIME-Version: 1.0
Subject: Mail delivery failed: returning message to sender
Message-Id: <E1t3Ot4-00000000OTX-1649@wh5.nita.go.ug>
Date: Wed, 23 Oct 2024 03:06:06 +0300

--1729641966-eximdsn-1623942687
Content-type: text/plain; charset=us-ascii

This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

  elvo8k@gmail.com
    host gmail-smtp-in.l.google.com [74.125.133.26]
    SMTP error from remote mail server after end of data:
    550-5.7.1 [154.72.194.117      19] Gmail has detected that this message is
    550-5.7.1 likely suspicious due to the very low reputation of the sending
    550-5.7.1 domain. To best protect our users from spam, the message has been
    550-5.7.1 blocked. For more information, go to
    550 5.7.1  https://support.google.com/mail/answer/188131 ffacd0b85a97d-37ee0bd760fsi2894205f8f.1076 - gsmtp

--1729641966-eximdsn-1623942687
Content-type: message/delivery-status

Reporting-MTA: dns; wh5.nita.go.ug

Action: failed
Final-Recipient: rfc822;elvo8k@gmail.com
Status: 5.0.0
Remote-MTA: dns; gmail-smtp-in.l.google.com
Diagnostic-Code: smtp; 550-5.7.1 [154.72.194.117      19] Gmail has detected that this message is
 550-5.7.1 likely suspicious due to the very low reputation of the sending
 550-5.7.1 domain. To best protect our users from spam, the message has been
 550-5.7.1 blocked. For more information, go to
 550 5.7.1  https://support.google.com/mail/answer/188131 ffacd0b85a97d-37ee0bd760fsi2894205f8f.1076 - gsmtp

--1729641966-eximdsn-1623942687
Content-type: message/rfc822

Return-path: <ncdcgo@wh5.nita.go.ug>
Received: from ncdcgo by wh5.nita.go.ug with local (Exim 4.97.1)
	(envelope-from <ncdcgo@wh5.nita.go.ug>)
	id 1t3Ot2-00000000OSc-1QXp
	for elvo8k@gmail.com;
	Wed, 23 Oct 2024 03:06:04 +0300
To: elvo8k@gmail.com
Subject: =?us-ascii?Q?[National_Curriculum_Development_Centre_(NCDC)]?=  =?us-ascii?Q?_Please_moderate:_"Addendum_on_A-Level_Chinese_?=  =?us-ascii?Q?Assessment"?=
X-PHP-Script: ncdc.go.ug/wp-comments-post.php for 185.190.42.200
X-PHP-Filename: /home/ncdcgo/public_html/wp-comments-post.php REMOTE_ADDR: 185.190.42.200
Date: Wed, 23 Oct 2024 00:06:04 +0000
From: WordPress <wordpress@ncdc.go.ug>
Message-ID: <NTKd76us8amVuvz2PONCEz6qy1qBqrtsk2qmHo34tI@ncdc.go.ug>
X-Mailer: PHPMailer 6.9.1 (https://github.com/PHPMailer/PHPMailer)
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8

A new comment on the post "Addendum on A-Level Chinese Assessment" is waiting for your approval
https://ncdc.go.ug/2024/05/09/addendum-on-a-level-chinese-assessment/

Author: Brobug (IP address: 185.190.42.200, 185.190.42.200)
Email: iunskiygipertonik@gmail.com
URL: https://true-pill.top/
Comment: 
The manufacturer of Ozempic and Wegovy has released a new version of the drug for weight loss, in the form of Rybelsus tablets with the same active ingredient Semaglutide. Rybelsus will help you lose weight quickly with a guarantee. 
 
What Is Rybelsus? 
 
Rybelsus is an oral (tablet) medication used to treat and manage Type 2 Diabetes, and for the treatment of weight loss. 
 
The active ingredient is Semaglutide which mimics the action of one of your bodies natural hormones (GLP1). It contains the same ingredient as Ozempic, which is a once weekly injection. Unlike the injections, Rebelsus is a tablet which is taken once daily. 
 
Multiple clinical studies have found patients on Rybelsus lose up their body weight. Patients also saw significant reductions in waist size and other measurements. 
 
https://rybelsus.true-pill.top/

Approve it: https://ncdc.go.ug/wp-admin/comment.php?action=approve&c=1375#wpbody-content
Trash it: https://ncdc.go.ug/wp-admin/comment.php?action=trash&c=1375#wpbody-content
Spam it: https://ncdc.go.ug/wp-admin/comment.php?action=spam&c=1375#wpbody-content
Currently 221 comments are waiting for approval. Please visit the moderation panel:
https://ncdc.go.ug/wp-admin/edit-comments.php?comment_status=moderated#wpbody-content


--1729641966-eximdsn-1623942687--